The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Ding, Zhao, Dr
    Director born in October 1985
    Individual (1 offspring)
    Officer
    2012-01-01 ~ now
    OF - Director → CIF 0
  • 2
    He, Ping
    Director born in October 1972
    Individual (4 offsprings)
    Officer
    2015-01-06 ~ now
    OF - Director → CIF 0
    He, Ping
    Individual (4 offsprings)
    Officer
    2014-11-24 ~ now
    OF - Secretary → CIF 0
  • 3
    Ding, Yao
    Director born in January 2000
    Individual (1 offspring)
    Officer
    2024-01-01 ~ now
    OF - Director → CIF 0
  • 4
    Mr Zhao Ding
    Born in October 1985
    Individual (3 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% as a member of a firm → CIF 0
Ceased 5
  • 1
    Mr Qianyi Huang
    Born in April 1993
    Individual
    Person with significant control
    2016-04-06 ~ 2022-02-09
    PE - Ownership of shares – More than 25% but not more than 50% as a member of a firm → CIF 0
  • 2
    Andrews, Douglas Bruce
    Born in May 1951
    Individual (3 offsprings)
    Officer
    2011-05-31 ~ 2014-10-15
    OF - Director → CIF 0
  • 3
    Attfield, Julian Michael Stuart
    Born in July 1962
    Individual (5 offsprings)
    Officer
    2011-05-31 ~ 2014-10-15
    OF - Director → CIF 0
    Attfield, Julian Michael Stuart
    Individual (5 offsprings)
    Officer
    2011-05-31 ~ 2014-10-15
    OF - Secretary → CIF 0
  • 4
    Chang, Fengkai
    Director born in May 1958
    Individual
    Officer
    2012-01-01 ~ 2013-04-26
    OF - Director → CIF 0
  • 5
    Hourigan, Marc Anthony
    Company Director born in March 1970
    Individual (8 offsprings)
    Officer
    2014-06-04 ~ 2015-01-06
    OF - Director → CIF 0
    Anthony, Marc Hourigan
    Individual (8 offsprings)
    Officer
    2014-10-30 ~ 2015-01-20
    OF - Secretary → CIF 0
parent relation
Company in focus

SEACROSS PHARMACEUTICALS LTD

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Par Value of Share
Class 1 ordinary share
12023-01-01 ~ 2023-12-31
Class 2 ordinary share
12023-01-01 ~ 2023-12-31
Intangible Assets
611,624 GBP2023-12-31
788,790 GBP2022-12-31
Property, Plant & Equipment
2,682 GBP2023-12-31
3,484 GBP2022-12-31
Fixed Assets - Investments
1,194,861 GBP2023-12-31
1,179,711 GBP2022-12-31
Fixed Assets
1,809,167 GBP2023-12-31
1,971,985 GBP2022-12-31
Total Inventories
1,008,227 GBP2023-12-31
1,110,021 GBP2022-12-31
Debtors
2,201,836 GBP2023-12-31
2,113,397 GBP2022-12-31
Cash at bank and in hand
3,231,883 GBP2023-12-31
3,123,904 GBP2022-12-31
Current Assets
6,441,946 GBP2023-12-31
6,347,322 GBP2022-12-31
Creditors
Current
4,351,009 GBP2023-12-31
5,069,538 GBP2022-12-31
Net Current Assets/Liabilities
2,090,937 GBP2023-12-31
1,277,784 GBP2022-12-31
Total Assets Less Current Liabilities
3,900,104 GBP2023-12-31
3,249,769 GBP2022-12-31
Equity
Called up share capital
6,000,000 GBP2023-12-31
6,000,000 GBP2022-12-31
Retained earnings (accumulated losses)
-2,099,896 GBP2023-12-31
-2,750,231 GBP2022-12-31
Equity
3,900,104 GBP2023-12-31
3,249,769 GBP2022-12-31
Average Number of Employees
42023-01-01 ~ 2023-12-31
42022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
1,735,472 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
1,123,848 GBP2023-12-31
946,682 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
177,166 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
611,624 GBP2023-12-31
788,790 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
2,679 GBP2023-12-31
2,679 GBP2022-12-31
Furniture and fittings
670 GBP2023-12-31
670 GBP2022-12-31
Computers
13,207 GBP2023-12-31
12,333 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
16,556 GBP2023-12-31
15,682 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
2,679 GBP2023-12-31
2,679 GBP2022-12-31
Furniture and fittings
670 GBP2023-12-31
670 GBP2022-12-31
Computers
10,525 GBP2023-12-31
8,849 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
13,874 GBP2023-12-31
12,198 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
1,676 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,676 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Computers
2,682 GBP2023-12-31
3,484 GBP2022-12-31
Investments in Group Undertakings
Cost valuation
1,884,799 GBP2023-12-31
1,717,799 GBP2022-12-31
Additions to investments
167,000 GBP2023-12-31
Investments in Group Undertakings
1,194,861 GBP2023-12-31
1,179,711 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
1,694,761 GBP2023-12-31
1,372,625 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
435,502 GBP2023-12-31
701,412 GBP2022-12-31
Other Debtors
Current
4,412 GBP2023-12-31
4,412 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
67,161 GBP2023-12-31
Amount of value-added tax that is recoverable
Current
34,948 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
2,201,836 GBP2023-12-31
2,113,397 GBP2022-12-31
Trade Creditors/Trade Payables
Current
189,597 GBP2023-12-31
335,834 GBP2022-12-31
Amounts owed to group undertakings
Current
3,162,600 GBP2023-12-31
4,220,977 GBP2022-12-31
Corporation Tax Payable
Current
23,001 GBP2023-12-31
2,683 GBP2022-12-31
Other Taxation & Social Security Payable
Current
6,393 GBP2023-12-31
5,257 GBP2022-12-31
Other Creditors
Current
1,869 GBP2023-12-31
2,000 GBP2022-12-31
Accrued Liabilities
Current
779,661 GBP2023-12-31
502,787 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
4,530,000 shares2023-12-31
Class 2 ordinary share
1,470,000 shares2023-12-31
Related profiles found in government register
  • SEACROSS PHARMACEUTICALS LTD
    Info
    Registered number 07650983
    Bedford Business Centre, 61-63 St Peters Street, Bedford, Bedfordshire MK40 2PR
    Private Limited Company incorporated on 2011-05-31 (14 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-05-31
    CIF 0
  • SEACROSS PHARMACEUTICALS LTD
    S
    Registered number 07650983
    Bedford Business Centre, 61-63 St Peters Street, Bedford, Bedfordshire, England, MK40 2PR
    Limited Company in England And Wales
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • HUIYU EUROPE LTD - 2016-10-27
    Stanmore Business & Innovation Centre Howard Road, Honeypot Lane, London, England
    Dissolved Corporate (3 parents)
    Equity (Company account)
    1,312 GBP2019-12-31
    Person with significant control
    2019-09-04 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.